Empaglifozin induces changes in the liver metabolome of diabetic rats.
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker

Health Research Institute of Santiago de Compostela and CIBERCV, Santiago de Compostela (Spain)
51 More presentations in this session
Doctor J. Jehle (Bonn, DE)
Doctor G. Katsuumi (Tokyo, JP)
Doctor E. Straessler (Berlin, DE)
Blocking of interleukin-1 suppresses both angiotensin II-induced renal inflammation and hypertension
Doctor T. Niida (Tokyo, JP)
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020
